Oishi Koseido Co., Ltd.

Form 483 issued September 1, 2023 · Tosu, Japan

Inspection
Aug 28 – Sep 1, 2023
Investigator
Teresa I. Navas
Observations
6
Pages
4
FEI number
3010166685

In short: On September 1, 2023, FDA issued a Form 483 with 6 observations to Oishi Koseido Co., Ltd. in Tosu, Saga (FEI 3010166685) after an inspection that ran Aug 28 – Sep 1, 2023. The investigator was Teresa I. Navas. Most observations concern production and facilities & equipment.

At a glance

Observations span 4 systems, led by production.

Production1
Facilities & equipment1
Packaging & labeling1
Laboratory controls1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Changes to written procedures are not drafted, reviewed and approved by…

  2. 02

    Input to and output from the computer and records or data are…

  3. 05

    Labeling and packaging materials are not representatively sampled upon receipt and before use in packaging and…

  4. 06

    Reserve samples from representative sample lots or batches of drug products selected by acceptable statistical procedures…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Oishi Koseido Co., Ltd.?

FDA listed 6 observations on this Form 483, mostly about production, facilities & equipment and packaging & labeling. The opening words of each observation are shown on this page.

Who inspected Oishi Koseido Co., Ltd.?

Teresa I. Navas is named on this Form 483, for the inspection of Aug 28 – Sep 1, 2023. Each investigator has a profile showing what they cite most.

When was Oishi Koseido Co., Ltd. inspected by FDA?

The inspection ran Aug 28 – Sep 1, 2023, and the Form 483 is dated September 1, 2023.

How do I get the full Form 483 for Oishi Koseido Co., Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free